Reactive arthritis

Current Opinion in Rheumatology

Volumn 12, Issue 4, 2000, Pages 300-305

  Toivanen, Auli ^b   Toivanen, Paavo ^a  

^a TURKU UNIVERSITY   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN;

ARTICLE; BACTERIAL INFECTION; CAMPYLOBACTER; CHLAMYDIA TRACHOMATIS; CLOSTRIDIUM DIFFICILE; DISEASE ASSOCIATION; HUMAN; IMMUNOPATHOGENESIS; PRIORITY JOURNAL; REACTIVE ARTHRITIS; SALMONELLA; SHIGELLA; YERSINIA ENTEROCOLITICA;

ANIMALS; ARTHRITIS, REACTIVE; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CIPROFLOXACIN; DNA, BACTERIAL; DOUBLE-BLIND METHOD; HLA-B27 ANTIGEN; HUMANS; RANDOMIZED CONTROLLED TRIALS; YERSINIA ENTEROCOLITICA; YERSINIA INFECTIONS;

EID: 0033932590     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200007000-00012     Document Type: Article

References (63)

1. 1 Sieper J, Braun J: Reactive arthritis. Curr Opin Rheumatol 1999. 11:238-243.
2. 2 González S, Martínez-Borra J, López-Larrea C: Immunogenetics, HLA-B27 and spondyloarthropathies. Curr Opin Rheumatol 1999, 11:257-264.
3. 3 Yu DTY: Pathogenesis of reactive arthritis. Intern Med 1999, 38:97-101.
4. 4 Gran JT: Classification and diagnosis of seronegative spondyloarthropathies. Scand J Rheumatol 1999, 28:332-335.
5. 5 Dougados M, van der Linden S, Juhlin R, et al., and The European Spondylarthropathy Study Group: The European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991, 34:1218-1227.
6. 6 Hülsemann JL, Zeidler H: Diagnostic evaluation of classification criteria for rheumatoid arthritis and reactive arthritis in an early synovitis outpatient clinic. Ann Rheum Dis 1999, 58:278-280.
7. 7 Amor B: Reiter's syndrome and reactive arthritis. Clin Rheumatol 1983, 2:315-319.
8. 8 Pacheco-Tena C, Burgos-Vargas R, Vázquez-Mellado J, et al.: A proposal for the classification of patients for clinic and experimental studies on reactive arthritis. J Rheumatol 1999, 26:1338-1346.
9. 9 Inman RD: Classification criteria for reactive arthritis. J Rheumatol 1999, 26:1219-1221.
10. 10 Sieper J, Braun J: Problems and advances in the diagnosis of reactive arthritis. J Rheumatol 1999, 26:1222-1224.
11. 11 Schumacher HR Jr, Arayssi T, Crane M, et al.: Chlamydia trachomatis nucleic acids can be found in the synovium of some asymptomatic subjects. Arthritis Rheum 1999, 42:1281-1284.
12. 12 Wilkinson NZ, Kingsley GH, Sieper J, et al.: Lack of correlation between the detection of Chlamydia trachomatis DNA in synovial fluid from patients with a range of rheumatic diseases and the presence of an antichlamydial immune response. Arthritis Rheum 1998, 41:845-854.
13. 13 Granfors K, Merilahti-Palo R, Luukkainen R, et al.: Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis. Arthritis Rheum 1998, 41:855-862.
14. 14 Kuipers JG, Köhler L, Zeidler H: Reactive or infectious arthritis. Ann Rheum Dis 1999, 58:661-664.
15. 15 Toivanen P, Toivanen A: Two forms of reactive arthritis? Ann Rheum Dis 1999, 58:737-741. A classification into HL4-B27-associated and nonassociated forms.
16. 16 Falcini F, Ferrari R, Simonini G, et al.: Recurrent monoarthritis in an 11-year-old boy with occult coeliac disease. Successful and stable remission after gluten-free diet. Clin Exp Rheumatol 1999, 17:509-511.
17. 17 El Maghraoui A, Dougados M, Freneaux E, et al.: Concordance between abdominal scintigraphy using technetium-99m hexamethylpropylene amine oxime-labelled leucocytes and ileocolonoscopy in patients with spondyloarthropathies and without clinical evidence of inflammatory bowel disease. Rheumatology 1999, 38:543-546.
18. 18 Toussirot E, Plesiat P, Wendling D: Reiter's syndrome induced by Gardnerella vaginalis (letter). Scand J Rheumatol 1998, 27:316-317.
19. 19 Laasila K, Leirisalo-Repo M: Recurrent reactive arthritis associated with urinary tract infection by Escherichia coli. J Rheumatol 1999, 26:2277-2279. An interesting report that confirms how trivial infections may be the cause of ReA.
20. 20 Schwartzenberg JM, Smith DD, Lindsley HB: Bacillus Calmette-Guérin associated arthropathy mimicking undifferentiated spondyloarthropathy. J Rheumatol 1999, 26:933-935.
21. 21 Clavel G, Grados F, Cayrolle G, et al.: Polyarthritis following intravesical BCG immunotherapy. Report of a case and review of 26 cases in the literature. Rev Rhum 1999, 66:115-118.
22. 22 Kocar IH, Caliskaner Z, Pay S, Turan M: Clostridium difficile infection in patients with reactive arthritis of undetermined etiology. Scand J Rheumatol 1998, 27:357-362.
23. 23 Veillard E, Guggenbuhl P, Bello S, et al.: Reactive oligoarthritis in a patient with Clostridium difficile pseudomembranous colitis: review of the literature. Rev Rhum 1998, 65:795-798.
24. 24 Kanakoudi-Tsakalidou F, Pardalos G, Pratsidou-Gertsi P, et al.: Persistent or severe course of reactive arthritis following Salmonella enteritidis infection. Scand J Rheumatol 1998, 27:431-434.
25. 25 Hannu T, Puolakkainen M, Leirisalo-Repo M: Chlamydia pneumoniae as a triggering infection in reactive arthritis. Rheumatology 1999, 38:411-414.
26. 26 Melby KK, Kvien TK, Glennȧs A, Ȧnestad G: Chlamydia pneumoniae as a trigger of reactive arthritis. Scand J Infect Dis 1999, 31:327-328.
27. 27 Schumacher HR Jr, Gérard HC, Arayssi TK, et al.: Lower prevalence of Chlamydia pneumoniae DNA compared with Chlamydia trachomatis DNA in synovial tissue of arthritis patients. Arthritis Rheum 1999, 42:1889-1893.
28. 28 Bas S, Scieux C, Vischer TL: Different humoral immune response to Chlamydia trachomatis major outer membrane protein variable domains I and IV in Chlamydia-infected patients with or without reactive arthritis. Arthritis Rheum 1999, 42:942-947.
29. 29 Lange U, Teichmann J: Diagnosis of Whipple's disease by molecular analysis of synovial fluid. Arthritis Rheum 1999, 42:1777-1778.
30. 30 O'Duffy JD, Griffing WL, Li C-Y, et al.: Whipple's arthritis. Direct detection of Tropheryma whippelii in synovial fluid and tissue. Arthritis Rheum 1999, 42:812-817.
31. 31 Wilbrink B, van der Heijden IM, Schouls LM, et al.: Detection of bacterial DNA in joint samples from patients with undifferentiated arthritis and reactive arthritis, using polymerase chain reaction with universal 16S ribosomal RNA primers. Arthritis Rheum 1998, 41:535-543.
32. 32 Kuipers JG, Jürgens-Saathoff B, Bialowons A, et al.: Detection of Chlamydia trachomatis in peripheral blood leukocytes of reactive arthritis patients by polymerase chain reaction. Arthritis Rheum 1998, 41:1894-1895.
33. 33 Gérard HC, Branigan PJ, Schumacher HR Jr, Hudson AP: Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol 1998, 25:734-742.
34. 34 Whittum-Hudson JA, Gérard HC, Clayburne G, et al.: A non-invasive murine model of Chlamydia-induced reactive arthritis. Rev Rhum 1999, 66:50S-56S.
35. 35 Nikkari S, Rantakokko K, Ekman P, et al.: Salmonella-triggered reactive arthritis. Use of polymerase chain reaction, immunocytochemical staining, and gas chromatography - mass spectrometry in the detection of bacterial components from synovial fluid. Arthritis Rheum 1999, 42:84-89.
36. 36 Ekman P, Nikkari S, Putto-Laurila A, et al.: Detection of Salmonella infantis in synovial fluid cells of a patient with reactive arthritis. J Rheumatol 1999, 26:2485-2488.
37. 37 Wuorela M, Tohka S, Granfors K, Jalkanen S: Monocytes that have ingested Yersinia enterocolitica serotype O:3 acquire enhanced capacity to bind to nonstimulated vascular endothelial cells via P-selectin. Infect Immun 1999, 67:726-732.
38. 38 Kirveskari J, He Q, Holmström T, et al.: Modulation of peripheral blood mononuclear cell activation status during Salmonella-triggered reactive arthritis. Arthritis Rheum 1999, 42:2045-2054.
39. 39 Isomäki P, Aversa G, Chang C-CJ, et al.: Expression of soluble human signaling lymphocytic activation molecule in vivo. J Allergy Clin Immunol 1999, 103:114-118.
40. 40 Huppertz H-I, Heesemann J: Effect of cytokines on invasion and survival of Yersinia in primary human fibroblasts. Med Microbiol Immunol 1999, 187:157-164.
41. 41 Toivanen A, Granfors K, Lahesmaa-Rantala R, et al.: Pathogenesis of Yersinia-triggered reactive arthritis: immunological, microbiological and clinical aspects. Immunol Rev 1985, 86:47-70.
42. 42 Skurnik M, Batsford S, Mertz A, et al.: The putative arthritogenic cationic 19-kilodalton antigen of Yersinia enterocolitica is a urease β-subunit. Infect Immun 1993, 61:2498-2504.
43. 43 Appel H, Mertz A, Distler A, et al.: The 19 kDa protein of Yersinia enterocolitica O:3 is recognized on the cellular and humoral level by patients with Yersinia induced reactive arthritis. J Rheumatol 1999, 26:1964-1971.
44. 44 Gripenberg-Lerche C, Zhang L, Ahtonen P, et al.: Construction of urease-negative mutants of Yersinia enterocolitica serotypes O:3 and O:8. Role of urease in virulence and arthritogenicity. Infect Immun 2000, 68:942-947.
45. 45 Matsumoto I, Staub A, Benoist C, Mathis D: Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 1999, 286:1732-1735.
46. 46 Reece RJ, Canete JD, Parsons WJ, et al.: Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis. Arthritis Rheum 1999, 42:1481-1484.
47. 47 Kim H-J, Krenn V, Steinhauser G, Berek C: Plasma cell development in synovial germinal centers in patients with rheumatoid and reactive arthritis. J Immunol 1999, 162:3053-3062.
48. 48 Ceponis A, Hietanen J, Tamulaitiene M, et al.: A comparative quantitative morphometric study of cell apoptosis in synovial membranes in psoriatic, reactive and rheumatoid arthritis. Rheumatology 1999, 38:431-440.
49. 49 López-Larrea C, González S, Martinez-Borra J: The role of HLA-B27 polymorphism and molecular mimicry in spondylarthropathy. Mol Med Today 1998, 4:540-549.
50. 50 Ringrose JH: HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27? Ann Rheum Dis 1999, 58:598-610.
51. 51 Braun J, Bollow M, Remlinger G, et al.: Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998, 41:58-67.
52. 52 Rivera-Civico F, Jiménez-Alonso J, Martin-Armada M, et al.: HLA-B27+ anterior uveitis with or without associated spondyloarthritis: clinical and immunological features. Ann Rheum Dis 1999, 58:721-722.
53. 53 Lee YH, Choi SJ, Yoon SY, et al.: Quantitative analysis of HLA-B27 by flow cytometry using CD3 gating in seronegative spondylarthropathies. Clin Exp Rheumatol 1999, 17:191-195.
54. 54 Allen RL, Bowness P, McMichael AJ: The role of HLA-B27 in spondyloarthritis. Immunogenetics 1999, 50:220-227.
55. 55 Dulphy N, Peyrat M-A, Tieng V, et al.: Common intra-articular T cell expansions in patients with reactive arthritis: identical β-chain junctional sequences and cytotoxicity toward HLA-B27. J Immunol 1999, 162:3830-3839.
56. 56 Falgarone G, Blanchard HS, Riot B, et al.: Cytotoxic T-cell-mediated response against Yersinia pseudotuberculosis in HLA-B27 transgenic rat. Infect Immun 1999, 67:3773-3779.
57. 57 Fiorillo MT, Greco G, Maragno M, et al.: The naturally occurring polymorphism Asp116 → His116, differentiating the ankylosing spondylitis-associated HLA-B*2705 from the non-associated HLA-B*2709 subtype, influences peptide-specific CD8 T cell recognition. Eur J Immunol 1998, 28:2508-2516.
58. 58 Tuokko J, Pushnova E, Yli-Kerttula U, et al.: TAP2 alleles in inflammatory arthritis. Scand J Rheumatol 1998, 27:225-229.
59. 59 Tuokko J, Koskinen S, Westman P, et al.: Tumour necrosis factor microsatellites in reactive arthritis. Brit J Rheumatol 1998, 37:1203-1206.
60. 60 Sieper J, Fendler C, Laitko S, et al.: No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis. Arthritis Rheum 1999, 42:1386-1396. A well-carried-out clinical study revealing the unusefulness of a 3-month course with antibiotics in the therapy of ReA. The disease duration was in most cases <3 months at the start of the treatment.
61. 61 Yli-Kerttula T, Luukkainen R, Yli-Kerttula U, et al.: Effect of a three-month course of ciprofloxacin on reactive arthritis. Presented in the XIV European League Against Rheumatism Congress, Glasgow, UK, June 6-11, 1999.
62. 62 Wakefield D, McCluskey P, Verma M, et al.: Ciprofloxacin treatment does not influence course or relapse rate of reactive arthritis and anterior uveitis. Arthritis Rheum 1999, 42:1894-1897.
63. 63 Clegg DO, Reda DJ, Abdellatif M: Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies. A Department of Veterans Affairs cooperative study. Arthritis Rheum 1999, 42:2325-2329.